Literature DB >> 10435570

Analysis of chromosome 22q as an aid to the diagnosis of rhabdoid tumor: a case report.

J Simons1, I Teshima, M Zielenska, V Edwards, G Taylor, J Squire, P Thorner.   

Abstract

Malignant rhabdoid tumor is a highly aggressive tumor of childhood that may present as a soft-tissue primary tumor. We report a soft-tissue neoplasm that was polyphenotypic by immunohistochemical expression of epithelial, mesenchymal, and neural markers and did not meet the criteria for any of the usual pediatric small round-cell tumors. The findings raised the diagnosis of rhabdoid tumor, leading to testing for WT1 mRNA and protein expression, which were positive, as has been reported for renal rhabdoid tumor. This tumor had the typical clinical behavior of rhabdoid tumor with therapy resistance and early tumor-related death. Multicolor spectral karyotyping of this neoplasm showed a balanced translocation between chromosomes 1 and 22 with breakpoints at 1p36 and 22q11-12. The latter region is commonly involved in rhabdoid tumor. This change was also identified by fluorescence in situ hybridization. This case suggests that studies of chromosome 22 may be required to distinguish rhabdoid tumor from other soft-tissue tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10435570     DOI: 10.1097/00000478-199908000-00018

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  3 in total

1.  Translocation (1;22)(p36;q11.2) with concurrent del(22)(q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor.

Authors:  Akiko Misawa; Hajime Hosoi; Issei Imoto; Tomoko Iehara; Tohru Sugimoto; Johji Inazawa
Journal:  J Hum Genet       Date:  2004-09-18       Impact factor: 3.172

2.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03

3.  Successful salvage and long-term survival after recurrent malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.